Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
Farxiga is expected to have such a strong influence on the market due to the impressive results
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Subscribe To Our Newsletter & Stay Updated
